EPIC trial ended

The EPIC trial data has now been published and shown significant benefit of pimobendan vs placebo in cases of advanced preclinical mitral valve disease, prolonging time to the development of symptoms and increasing longevity. This is very exciting news for many small breed dogs with this potentially life threatening disease

- Return to News -